Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

IL-9 receptor signaling in memory B cells regulates humoral recall responses.

Takatsuka S, Yamada H, Haniuda K, Saruwatari H, Ichihashi M, Renauld JC, Kitamura D.

Nat Immunol. 2018 Aug 6. doi: 10.1038/s41590-018-0177-0. [Epub ahead of print]

PMID:
30082831
2.

IL-9 and Mast Cells Are Key Players of Candida albicans Commensalism and Pathogenesis in the Gut.

Renga G, Moretti S, Oikonomou V, Borghi M, Zelante T, Paolicelli G, Costantini C, De Zuani M, Villella VR, Raia V, Del Sordo R, Bartoli A, Baldoni M, Renauld JC, Sidoni A, Garaci E, Maiuri L, Pucillo C, Romani L.

Cell Rep. 2018 May 8;23(6):1767-1778. doi: 10.1016/j.celrep.2018.04.034.

3.

Interleukin-22-deficiency and microbiota contribute to the exacerbation of Toxoplasma gondii-induced intestinal inflammation.

Couturier-Maillard A, Froux N, Piotet-Morin J, Michaudel C, Brault L, Le Bérichel J, Sénéchal A, Robinet P, Chenuet P, Jejou S, Dumoutier L, Renauld JC, Iovanna J, Huber S, Quesniaux V, Sokol H, Ryffel B.

Mucosal Immunol. 2018 Jul;11(4):1181-1190. doi: 10.1038/s41385-018-0005-8. Epub 2018 May 4.

PMID:
29728643
4.

Interleukin-22 level is negatively correlated with neutrophil recruitment in the lungs in a Pseudomonas aeruginosa pneumonia model.

Broquet A, Jacqueline C, Davieau M, Besbes A, Roquilly A, Martin J, Caillon J, Dumoutier L, Renauld JC, Heslan M, Josien R, Asehnoune K.

Sci Rep. 2017 Sep 8;7(1):11010. doi: 10.1038/s41598-017-11518-0.

5.

IL-22 induces Reg3γ and inhibits allergic inflammation in house dust mite-induced asthma models.

Ito T, Hirose K, Saku A, Kono K, Takatori H, Tamachi T, Goto Y, Renauld JC, Kiyono H, Nakajima H.

J Exp Med. 2017 Oct 2;214(10):3037-3050. doi: 10.1084/jem.20162108. Epub 2017 Aug 15.

6.

Can serum cytokine profile discriminate irritant-induced and allergen-induced symptoms? A cross-sectional study in workers mostly exposed to laboratory animals.

Lemaire M, Oppliger A, Hotz P, Renauld JC, Braun J, Maggi M, Barresi F, Schmid-Grendelmeier P, Huaux F, Dressel H.

Occup Environ Med. 2017 Aug;74(8):592-600. doi: 10.1136/oemed-2016-104137. Epub 2017 Apr 17.

PMID:
28416643
7.

Limited Presence of IL-22 Binding Protein, a Natural IL-22 Inhibitor, Strengthens Psoriatic Skin Inflammation.

Martin JC, Wolk K, Bériou G, Abidi A, Witte-Händel E, Louvet C, Kokolakis G, Drujont L, Dumoutier L, Renauld JC, Sabat R, Josien R.

J Immunol. 2017 May 1;198(9):3671-3678. doi: 10.4049/jimmunol.1700021. Epub 2017 Mar 29.

8.

MacroH2A histone variants maintain nuclear organization and heterochromatin architecture.

Douet J, Corujo D, Malinverni R, Renauld J, Sansoni V, Posavec Marjanović M, Cantariño N, Valero V, Mongelard F, Bouvet P, Imhof A, Thiry M, Buschbeck M.

J Cell Sci. 2017 May 1;130(9):1570-1582. doi: 10.1242/jcs.199216. Epub 2017 Mar 10.

9.

Ccr6 Is Dispensable for the Development of Skin Lesions Induced by Imiquimod despite its Effect on Epidermal Homing of IL-22-Producing Cells.

Cochez PM, Michiels C, Hendrickx E, Dauguet N, Warnier G, Renauld JC, Dumoutier L.

J Invest Dermatol. 2017 May;137(5):1094-1103. doi: 10.1016/j.jid.2016.12.023. Epub 2017 Jan 20.

10.

A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis.

Moretti S, Renga G, Oikonomou V, Galosi C, Pariano M, Iannitti RG, Borghi M, Puccetti M, De Zuani M, Pucillo CE, Paolicelli G, Zelante T, Renauld JC, Bereshchenko O, Sportoletti P, Lucidi V, Russo MC, Colombo C, Fiscarelli E, Lass-Flörl C, Majo F, Ricciotti G, Ellemunter H, Ratclif L, Talesa VN, Napolioni V, Romani L.

Nat Commun. 2017 Jan 16;8:14017. doi: 10.1038/ncomms14017.

11.

Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22.

Porte R, Van Maele L, Muñoz-Wolf N, Foligné B, Dumoutier L, Tabareau J, Cayet D, Gosset P, Jonckheere N, Van Seuningen I, Chabalgoity JA, Simonet M, Lamkanfi M, Renauld JC, Sirard JC, Carnoy C.

Infect Immun. 2017 Jan 26;85(2). pii: e00806-16. doi: 10.1128/IAI.00806-16. Print 2017 Feb.

12.

Corrigendum: Distinct Transcriptomic Features Are Associated with Transitional and Mature B-Cell Populations in the Mouse Spleen.

Kleiman E, Salyakina D, De Heusch M, Hoek KL, Llanes JM, Castro I, Wright JA, Clark ES, Dykxhoorn DM, Capobianco E, Takeda A, McCormack RM, Podack ER, Renauld JC, Khan WN.

Front Immunol. 2016 Jul 4;7:267. doi: 10.3389/fimmu.2016.00267. eCollection 2016.

13.

Loss of mutL homolog-1 (MLH1) expression promotes acquisition of oncogenic and inhibitor-resistant point mutations in tyrosine kinases.

Springuel L, Losdyck E, Saussoy P, Turcq B, Mahon FX, Knoops L, Renauld JC.

Cell Mol Life Sci. 2016 Dec;73(24):4739-4748. Epub 2016 Jul 19.

PMID:
27436342
14.

IL-22-induced antimicrobial peptides are key determinants of mucosal vaccine-induced protection against H. pylori in mice.

Moyat M, Bouzourene H, Ouyang W, Iovanna J, Renauld JC, Velin D.

Mucosal Immunol. 2017 Jan;10(1):271-281. doi: 10.1038/mi.2016.38. Epub 2016 May 4.

PMID:
27143303
15.

Interleukin-22 regulates antimicrobial peptide expression and keratinocyte differentiation to control Staphylococcus aureus colonization of the nasal mucosa.

Mulcahy ME, Leech JM, Renauld JC, Mills KH, McLoughlin RM.

Mucosal Immunol. 2016 Nov;9(6):1429-1441. doi: 10.1038/mi.2016.24. Epub 2016 Mar 23.

PMID:
27007677
16.

AhR modulates the IL-22-producing cell proliferation/recruitment in imiquimod-induced psoriasis mouse model.

Cochez PM, Michiels C, Hendrickx E, Van Belle AB, Lemaire MM, Dauguet N, Warnier G, de Heusch M, Togbe D, Ryffel B, Coulie PG, Renauld JC, Dumoutier L.

Eur J Immunol. 2016 Jun;46(6):1449-59. doi: 10.1002/eji.201546070.

17.

Complementarity and redundancy of IL-22-producing innate lymphoid cells.

Rankin LC, Girard-Madoux MJ, Seillet C, Mielke LA, Kerdiles Y, Fenis A, Wieduwild E, Putoczki T, Mondot S, Lantz O, Demon D, Papenfuss AT, Smyth GK, Lamkanfi M, Carotta S, Renauld JC, Shi W, Carpentier S, Soos T, Arendt C, Ugolini S, Huntington ND, Belz GT, Vivier E.

Nat Immunol. 2016 Feb;17(2):179-86. doi: 10.1038/ni.3332. Epub 2015 Nov 30.

18.

Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities.

Losdyck E, Hornakova T, Springuel L, Degryse S, Gielen O, Cools J, Constantinescu SN, Flex E, Tartaglia M, Renauld JC, Knoops L.

J Biol Chem. 2015 Nov 27;290(48):29022-34. doi: 10.1074/jbc.M115.670224. Epub 2015 Oct 7.

19.

JAK kinase targeting in hematologic malignancies: a sinuous pathway from identification of genetic alterations towards clinical indications.

Springuel L, Renauld JC, Knoops L.

Haematologica. 2015 Oct;100(10):1240-53. doi: 10.3324/haematol.2015.132142. Review.

20.

MicroRNA-124 Regulates Cell Specification in the Cochlea through Modulation of Sfrp4/5.

Huyghe A, Van den Ackerveken P, Sacheli R, Prévot PP, Thelen N, Renauld J, Thiry M, Delacroix L, Nguyen L, Malgrange B.

Cell Rep. 2015 Oct 6;13(1):31-42. doi: 10.1016/j.celrep.2015.08.054. Epub 2015 Sep 17.

21.

IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis.

Martin JC, Bériou G, Heslan M, Bossard C, Jarry A, Abidi A, Hulin P, Ménoret S, Thinard R, Anegon I, Jacqueline C, Lardeux B, Halary F, Renauld JC, Bourreille A, Josien R.

Mucosal Immunol. 2016 Mar;9(2):539-49. doi: 10.1038/mi.2015.83. Epub 2015 Sep 2.

PMID:
26329427
22.

Neutrophil proteases alter the interleukin-22-receptor-dependent lung antimicrobial defence.

Guillon A, Jouan Y, Brea D, Gueugnon F, Dalloneau E, Baranek T, Henry C, Morello E, Renauld JC, Pichavant M, Gosset P, Courty Y, Diot P, Si-Tahar M.

Eur Respir J. 2015 Sep;46(3):771-82. doi: 10.1183/09031936.00215114. Epub 2015 Aug 6.

23.

Spatio-temporal dynamics of β-tubulin isotypes during the development of the sensory auditory organ in rat.

Renauld J, Johnen N, Thelen N, Cloes M, Thiry M.

Histochem Cell Biol. 2015 Nov;144(5):403-16. doi: 10.1007/s00418-015-1350-2. Epub 2015 Jul 26.

24.

Donor interleukin-22 and host type I interferon signaling pathway participate in intestinal graft-versus-host disease via STAT1 activation and CXCL10.

Lamarthée B, Malard F, Gamonet C, Bossard C, Couturier M, Renauld JC, Mohty M, Saas P, Gaugler B.

Mucosal Immunol. 2016 Mar;9(2):309-21. doi: 10.1038/mi.2015.61. Epub 2015 Jul 8.

PMID:
26153763
25.

Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection.

Hernández PP, Mahlakoiv T, Yang I, Schwierzeck V, Nguyen N, Guendel F, Gronke K, Ryffel B, Hoelscher C, Dumoutier L, Renauld JC, Suerbaum S, Staeheli P, Diefenbach A.

Nat Immunol. 2015 Jul;16(7):698-707. doi: 10.1038/ni.3180. Epub 2015 May 25.

26.

Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo.

Cuende J, Liénart S, Dedobbeleer O, van der Woning B, De Boeck G, Stockis J, Huygens C, Colau D, Somja J, Delvenne P, Hannon M, Baron F, Dumoutier L, Renauld JC, De Haard H, Saunders M, Coulie PG, Lucas S.

Sci Transl Med. 2015 Apr 22;7(284):284ra56. doi: 10.1126/scitranslmed.aaa1983.

27.

Distinct Transcriptomic Features are Associated with Transitional and Mature B-Cell Populations in the Mouse Spleen.

Kleiman E, Salyakina D, De Heusch M, Hoek KL, Llanes JM, Castro I, Wright JA, Clark ES, Dykxhoorn DM, Capobianco E, Takeda A, Renauld JC, Khan WN.

Front Immunol. 2015 Feb 11;6:30. doi: 10.3389/fimmu.2015.00030. eCollection 2015. Erratum in: Front Immunol. 2016;7:267.

28.

Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status.

Everard A, Geurts L, Caesar R, Van Hul M, Matamoros S, Duparc T, Denis RG, Cochez P, Pierard F, Castel J, Bindels LB, Plovier H, Robine S, Muccioli GG, Renauld JC, Dumoutier L, Delzenne NM, Luquet S, Bäckhed F, Cani PD.

Nat Commun. 2014 Dec 5;5:5648. doi: 10.1038/ncomms6648.

29.

The chemokine receptor CXCR6 controls the functional topography of interleukin-22 producing intestinal innate lymphoid cells.

Satoh-Takayama N, Serafini N, Verrier T, Rekiki A, Renauld JC, Frankel G, Di Santo JP.

Immunity. 2014 Nov 20;41(5):776-88. doi: 10.1016/j.immuni.2014.10.007. Epub 2014 Nov 6.

30.

IL-1α induces CD11b(low) alveolar macrophage proliferation and maturation during granuloma formation.

Huaux F, Lo Re S, Giordano G, Uwambayinema F, Devosse R, Yakoub Y, Panin N, Palmai-Pallag M, Rabolli V, Delos M, Marbaix E, Dauguet N, Couillin I, Ryffel B, Renauld JC, Lison D.

J Pathol. 2015 Apr;235(5):698-709. doi: 10.1002/path.4487. Epub 2015 Jan 20.

PMID:
25421226
31.

Cooperating JAK1 and JAK3 mutants increase resistance to JAK inhibitors.

Springuel L, Hornakova T, Losdyck E, Lambert F, Leroy E, Constantinescu SN, Flex E, Tartaglia M, Knoops L, Renauld JC.

Blood. 2014 Dec 18;124(26):3924-31. doi: 10.1182/blood-2014-05-576652. Epub 2014 Oct 28.

32.

Idiopathic basal ganglia calcification-associated PDGFRB mutations impair the receptor signalling.

Arts FA, Velghe AI, Stevens M, Renauld JC, Essaghir A, Demoulin JB.

J Cell Mol Med. 2015 Jan;19(1):239-48. doi: 10.1111/jcmm.12443. Epub 2014 Oct 8.

33.

Extensive profiling of the expression of the indoleamine 2,3-dioxygenase 1 protein in normal and tumoral human tissues.

Théate I, van Baren N, Pilotte L, Moulin P, Larrieu P, Renauld JC, Hervé C, Gutierrez-Roelens I, Marbaix E, Sempoux C, Van den Eynde BJ.

Cancer Immunol Res. 2015 Feb;3(2):161-72. doi: 10.1158/2326-6066.CIR-14-0137. Epub 2014 Sep 30.

34.

Innate lymphoid cells regulate intestinal epithelial cell glycosylation.

Goto Y, Obata T, Kunisawa J, Sato S, Ivanov II, Lamichhane A, Takeyama N, Kamioka M, Sakamoto M, Matsuki T, Setoyama H, Imaoka A, Uematsu S, Akira S, Domino SE, Kulig P, Becher B, Renauld JC, Sasakawa C, Umesaki Y, Benno Y, Kiyono H.

Science. 2014 Sep 12;345(6202):1254009. doi: 10.1126/science.1254009. Epub 2014 Aug 21.

35.

Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection.

Van Maele L, Carnoy C, Cayet D, Ivanov S, Porte R, Deruy E, Chabalgoity JA, Renauld JC, Eberl G, Benecke AG, Trottein F, Faveeuw C, Sirard JC.

J Infect Dis. 2014 Aug 1;210(3):493-503. doi: 10.1093/infdis/jiu106. Epub 2014 Feb 26.

PMID:
24577508
36.

IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation.

Turner JE, Morrison PJ, Wilhelm C, Wilson M, Ahlfors H, Renauld JC, Panzer U, Helmby H, Stockinger B.

J Exp Med. 2013 Dec 16;210(13):2951-65. doi: 10.1084/jem.20130071. Epub 2013 Nov 18.

37.

Tumor necrosis factor receptor signaling in keratinocytes triggers interleukin-24-dependent psoriasis-like skin inflammation in mice.

Kumari S, Bonnet MC, Ulvmar MH, Wolk K, Karagianni N, Witte E, Uthoff-Hachenberg C, Renauld JC, Kollias G, Toftgard R, Sabat R, Pasparakis M, Haase I.

Immunity. 2013 Nov 14;39(5):899-911. doi: 10.1016/j.immuni.2013.10.009. Epub 2013 Nov 7.

38.

Asthma related to cleaning agents: a clinical insight.

Vandenplas O, D'Alpaos V, Evrard G, Jamart J, Thimpont J, Huaux F, Renauld JC.

BMJ Open. 2013 Sep 19;3(9):e003568. doi: 10.1136/bmjopen-2013-003568.

39.

Lung inflammation and thymic atrophy after bleomycin are controlled by the prostaglandin D2 receptor DP1.

van den Brule S, Huaux F, Uwambayinema F, Ibouraadaten S, Yakoub Y, Palmai-Pallag M, Trottein F, Renauld JC, Lison D.

Am J Respir Cell Mol Biol. 2014 Jan;50(1):212-22. doi: 10.1165/rcmb.2012-0520OC.

PMID:
24003988
40.

Cancer risk in immune-mediated inflammatory diseases (IMID).

Beyaert R, Beaugerie L, Van Assche G, Brochez L, Renauld JC, Viguier M, Cocquyt V, Jerusalem G, Machiels JP, Prenen H, Masson P, Louis E, De Keyser F.

Mol Cancer. 2013 Aug 29;12(1):98. doi: 10.1186/1476-4598-12-98. Review.

41.

Activation of the Janus kinase/signal transducer and activator of transcription pathway in multiple myeloma is not related to point mutations in kinase and pseudokinase domains of JAK1.

Corbi FC, de Oliveira MB, Morelli VM, Han SW, Renauld JC, Knoops L, Colleoni GW.

Leuk Lymphoma. 2014 May;55(5):1176-80. doi: 10.3109/10428194.2013.828352. Epub 2013 Sep 3.

PMID:
23885837
42.

Characterization of the T cell response in allergic contact dermatitis caused by corticosteroids.

Baeck M, Soria A, Marot L, Theate I, Hendrickx E, Van Belle A, Goossens A, Tennstedt D, Dachelet C, Jaeger J, Pilette C, Renauld JC, Van Baren N, Rozières A, Nicolas JF, Dumoutier L.

Contact Dermatitis. 2013 Jun;68(6):357-68. doi: 10.1111/cod.12040.

PMID:
23692036
43.

Mucosal and systemic immune responses to Mycobacterium tuberculosis antigen 85A following its co-delivery with CpG, MPLA or LTB to the lungs in mice.

Todoroff J, Lemaire MM, Fillee C, Jurion F, Renauld JC, Huygen K, Vanbever R.

PLoS One. 2013 May 10;8(5):e63344. doi: 10.1371/journal.pone.0063344. Print 2013.

44.

Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection.

Ivanov S, Renneson J, Fontaine J, Barthelemy A, Paget C, Fernandez EM, Blanc F, De Trez C, Van Maele L, Dumoutier L, Huerre MR, Eberl G, Si-Tahar M, Gosset P, Renauld JC, Sirard JC, Faveeuw C, Trottein F.

J Virol. 2013 Jun;87(12):6911-24. doi: 10.1128/JVI.02943-12. Epub 2013 Apr 17.

45.

IL-22 modulates IL-17A production and controls inflammation and tissue damage in experimental dengue infection.

Guabiraba R, Besnard AG, Marques RE, Maillet I, Fagundes CT, Conceição TM, Rust NM, Charreau S, Paris I, Lecron JC, Renauld JC, Quesniaux V, Da Poian AT, Arruda LB, Souza DG, Ryffel B, Teixeira MM.

Eur J Immunol. 2013 Jun;43(6):1529-44. doi: 10.1002/eji.201243229. Epub 2013 Apr 17.

46.

IL-22 is mainly produced by IFNγ-secreting cells but is dispensable for host protection against Mycobacterium tuberculosis infection.

Behrends J, Renauld JC, Ehlers S, Hölscher C.

PLoS One. 2013;8(2):e57379. doi: 10.1371/journal.pone.0057379. Epub 2013 Feb 27.

47.

IL-22 deficiency in donor T cells attenuates murine acute graft-versus-host disease mortality while sparing the graft-versus-leukemia effect.

Couturier M, Lamarthée B, Arbez J, Renauld JC, Bossard C, Malard F, Bonnefoy F, Mohty M, Perruche S, Tiberghien P, Saas P, Gaugler B.

Leukemia. 2013 Jul;27(7):1527-37. doi: 10.1038/leu.2013.39. Epub 2013 Feb 12.

PMID:
23399894
48.

Targeting the deep lungs, Poloxamer 407 and a CpG oligonucleotide optimize immune responses to Mycobacterium tuberculosis antigen 85A following pulmonary delivery.

Todoroff J, Ucakar B, Inglese M, Vandermarliere S, Fillee C, Renauld JC, Huygen K, Vanbever R.

Eur J Pharm Biopharm. 2013 May;84(1):40-8. doi: 10.1016/j.ejpb.2012.11.020. Epub 2012 Dec 11.

PMID:
23238272
49.

Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk.

Tortola L, Rosenwald E, Abel B, Blumberg H, Schäfer M, Coyle AJ, Renauld JC, Werner S, Kisielow J, Kopf M.

J Clin Invest. 2012 Nov;122(11):3965-76. doi: 10.1172/JCI63451. Epub 2012 Oct 15.

50.

IL-22 Protects Against Liver Pathology and Lethality of an Experimental Blood-Stage Malaria Infection.

Mastelic B, do Rosario AP, Veldhoen M, Renauld JC, Jarra W, Sponaas AM, Roetynck S, Stockinger B, Langhorne J.

Front Immunol. 2012 Apr 25;3:85. doi: 10.3389/fimmu.2012.00085. eCollection 2012.

Supplemental Content

Loading ...
Support Center